tyrosine and Acute Disease

Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses

Topics: Acute Disease; Animals; Chronic Disease; Humans; Oxidative Stress; Stereoisomerism; Tyrosine

Topics: Abciximab; Acute Disease; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Coronary Disease; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Tirofiban; Tyrosine

Topics: Acute Disease; Coronary Disease; Enoxaparin; Female; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Male; Myocardial Reperfusion; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombolytic Therapy; Tirofiban; Tyrosine

Topics: Acute Disease; Angina, Unstable; Anticoagulants; Drug Therapy, Combination; Heparin; Humans; Logistic Models; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prognosis; Recurrence; Risk Assessment; Thrombolytic Therapy; Tirofiban; Troponin; Tyrosine

Topics: Abciximab; Acute Disease; Adrenergic beta-Antagonists; Angina, Unstable; Antibodies, Monoclonal; Anticholesteremic Agents; Arrhythmias, Cardiac; Aspirin; Atorvastatin; Clopidogrel; Defibrillators, Implantable; Double-Blind Method; Fibrinolytic Agents; Heart Failure; Heart Septal Defects, Atrial; Heart Transplantation; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoglobulin Fab Fragments; Myocardial Infarction; Placebos; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrroles; Quality of Life; Randomized Controlled Trials as Topic; Regeneration; Risk Factors; Syndrome; Ticlopidine; Time Factors; Tirofiban; Tyrosine

Topics: Abciximab; Acetates; Acute Disease; Antibodies, Monoclonal; Coronary Disease; Drug Evaluation; Eptifibatide; Guidelines as Topic; Humans; Immunoglobulin Fab Fragments; Incidence; Injections, Intravenous; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Risk Assessment; Tirofiban; Treatment Outcome; Tyrosine

Topics: Abciximab; Acute Disease; Aged; Antibodies, Monoclonal; Coronary Disease; Eptifibatide; Female; Humans; Immunoglobulin Fab Fragments; Male; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Risk Assessment; Syndrome; Tirofiban; Tyrosine

Topics: Abciximab; Acetates; Acute Disease; Antibodies, Monoclonal; Coronary Disease; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Injections, Intravenous; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Tirofiban; Tyrosine

Topics: Acute Disease; Angina, Unstable; Angioplasty, Balloon, Coronary; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Myocardial Infarction; Platelet Glycoprotein GPIIb-IIIa Complex; Syndrome; Tirofiban; Tyrosine

Topics: Acute Disease; Administration, Oral; Blood Platelets; Coronary Artery Bypass; Coronary Disease; Emergencies; Humans; Infusions, Intravenous; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Hemorrhage; Thrombocytopenia; Tirofiban; Tyrosine

Topics: Abciximab; Acute Disease; Animals; Antibodies, Monoclonal; Brain Ischemia; Clinical Trials as Topic; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stroke; Tirofiban; Tyrosine

Topics: Abciximab; Acetates; Acute Disease; Antibodies, Monoclonal; Blood Platelets; Coronary Disease; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Injections, Intravenous; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Syndrome; Tirofiban; Tyrosine

Topics: Acetates; Acute Disease; Anticoagulants; Coronary Disease; Drug Therapy, Combination; Eptifibatide; Heparin; Humans; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Tirofiban; Tyrosine

Topics: Acute Disease; Coronary Disease; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Tirofiban; Tissue Distribution; Tyrosine

Topics: Abciximab; Acetates; Acute Disease; Administration, Oral; Angina, Unstable; Antibodies, Monoclonal; Clinical Trials as Topic; Coronary Disease; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Infusions, Intravenous; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Tyrosine

Topics: Acute Disease; Anticoagulants; Aspirin; Clinical Trials as Topic; Coronary Disease; Coronary Thrombosis; Eptifibatide; Fibrinolytic Agents; Heparin; Humans; Myocardial Ischemia; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Tyrosine

Topics: Abciximab; Acute Disease; Antibodies, Monoclonal; Blood Platelets; Coronary Artery Bypass; Coronary Disease; Coronary Thrombosis; Eptifibatide; Fibrinolytic Agents; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Incidence; Myocardial Ischemia; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Risk Factors; Safety; Tirofiban; Tyrosine

Topics: Abciximab; Acute Disease; Antibodies, Monoclonal; Coronary Disease; Drug Therapy, Combination; Electrocardiography; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Treatment Outcome; Tyrosine

Topics: Acute Disease; Clinical Trials as Topic; Coronary Disease; Electrocardiography; Eptifibatide; Humans; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Risk Factors; Syndrome; Tirofiban; Tyrosine

Topics: Abciximab; Acetates; Acute Disease; Antibodies, Monoclonal; Humans; Immunoglobulin Fab Fragments; Myocardial Ischemia; Platelet Glycoprotein GPIIb-IIIa Complex; Syndrome; Tirofiban; Tyrosine

Topics: Abciximab; Acetates; Acute Disease; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Coronary Disease; Drug Therapy, Combination; Eptifibatide; Heparin; Humans; Immunoglobulin Fab Fragments; Incidence; Infusions, Intravenous; Intracranial Hemorrhages; Odds Ratio; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Syndrome; Tirofiban; Tyrosine

Topics: Abciximab; Acetates; Acute Disease; Administration, Oral; Alanine; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Benzamidines; Coronary Disease; Eptifibatide; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Oximes; Peptides; Piperidines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrrolidines; Randomized Controlled Trials as Topic; Stents; Syndrome; Thrombocytopenia; Thrombolytic Therapy; Tirofiban; Tyrosine

Topics: Acetates; Acute Disease; Eptifibatide; Hemorrhage; Humans; Myocardial Infarction; Myocardial Ischemia; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Risk Factors; Survival Analysis; Tirofiban; Tyrosine

Topics: Abciximab; Acute Disease; Alanine; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Benzamidines; Drug Therapy, Combination; Eptifibatide; Heparin, Low-Molecular-Weight; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Oximes; Peptides; Piperidines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrrolidines; Randomized Controlled Trials as Topic; Stents; Tirofiban; Tyrosine

Topics: Acute Disease; Administration, Oral; Adrenergic beta-Antagonists; Angina, Unstable; Anticoagulants; Aspirin; Calcium Channel Blockers; Clinical Trials as Topic; Clopidogrel; Electrocardiography; Fibrinolytic Agents; Humans; Multicenter Studies as Topic; Myocardial Infarction; Nitrates; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Risk Factors; Syndrome; Terminology as Topic; Ticlopidine; Tirofiban; Tyrosine

Topics: Abciximab; Acute Disease; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Atherectomy; Clinical Trials as Topic; Coronary Disease; Eptifibatide; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Placebos; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Syndrome; Time Factors; Tirofiban; Treatment Outcome; Troponin T; Tyrosine

Topics: Abciximab; Acute Disease; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Dose-Response Relationship, Drug; Drug Administration Schedule; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Syndrome; Time Factors; Tirofiban; Treatment Outcome; Tyrosine

Topics: Acute Disease; Adult; Aged; Amino Acids; Binding, Competitive; Blood-Brain Barrier; Brain; Brain Diseases; Female; Hepatitis; Humans; Hydroxylation; Isoleucine; Leucine; Male; Middle Aged; Neurotransmitter Agents; Phenylalanine; Tyrosine; Valine

Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses

Topics: Acute Disease; Aged; Aspirin; Carotid Artery Thrombosis; Carotid Artery, Internal; Cerebral Revascularization; Clopidogrel; Endovascular Procedures; Feasibility Studies; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Severity of Illness Index; Stents; Thrombectomy; Ticlopidine; Tirofiban; Treatment Outcome; Tyrosine

Topics: Acute Disease; Aged; Angioplasty, Balloon, Coronary; Cohort Studies; Coronary Disease; Coronary Vessels; Female; Humans; Incidence; Male; Middle Aged; Platelet Aggregation Inhibitors; Severity of Illness Index; Survival Analysis; Syndrome; Tirofiban; Treatment Outcome; Tyrosine

Topics: Abciximab; Acute Disease; Aged; Amino Acid Chloromethyl Ketones; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Citric Acid; Coronary Disease; Eptifibatide; Female; Humans; Immunoglobulin Fab Fragments; Kinetics; Male; Middle Aged; Myocardial Infarction; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Syndrome; Tirofiban; Tyrosine

Topics: Acute Disease; Aged; Angina Pectoris; Biomarkers; C-Reactive Protein; Coronary Angiography; Coronary Artery Disease; Fees, Pharmaceutical; Female; Fibrinolytic Agents; Humans; Leukocyte Count; Male; Middle Aged; Multivariate Analysis; Severity of Illness Index; Smoking; Statistics as Topic; Stroke Volume; Survival Analysis; Syndrome; Tirofiban; Tyrosine

Topics: Acute Disease; Aged; Angina, Unstable; Cardiac Catheterization; Coronary Disease; Creatinine; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Renal Insufficiency; Risk Factors; Tirofiban; Treatment Outcome; Tyrosine

Topics: Acetates; Acute Disease; Aged; Anticoagulants; Coronary Disease; Data Interpretation, Statistical; Drug Therapy, Combination; Female; Heparin; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Myocardial Revascularization; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Survival Analysis; Tyrosine

Topics: Acetates; Acute Disease; Aged; Coronary Disease; Electrocardiography; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prognosis; Risk Assessment; Syndrome; Time Factors; Troponin T; Tyrosine

Topics: Acetates; Acute Disease; Aged; Arrhythmias, Cardiac; Coronary Disease; Disease-Free Survival; Electrocardiography; Female; Hospitalization; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prognosis; Survival Analysis; Troponin T; Tyrosine

Topics: Acetates; Acute Disease; Aged; Aged, 80 and over; Coronary Disease; Female; Heparin; Humans; Infusions, Intravenous; Logistic Models; Male; Middle Aged; Monitoring, Physiologic; Odds Ratio; Partial Thromboplastin Time; Point-of-Care Systems; Syndrome; Tyrosine

Topics: Acute Disease; Angioplasty, Balloon, Coronary; Coronary Angiography; Electrocardiography; Emergency Treatment; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Care; Preoperative Care; Tirofiban; Treatment Outcome; Tyrosine

Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Diffusion Magnetic Resonance Imaging; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fibrinolytic Agents; Humans; Infarction, Middle Cerebral Artery; Magnetic Resonance Angiography; Male; Middle Aged; Platelet Glycoprotein GPIIb-IIIa Complex; Recombinant Proteins; Thrombolytic Therapy; Tirofiban; Tissue Plasminogen Activator; Treatment Outcome; Tyrosine

Topics: Acute Disease; Aged; Angina, Unstable; Biomarkers; C-Reactive Protein; Combined Modality Therapy; Creatine Kinase; Creatine Kinase, MB Form; Female; Fibrinolytic Agents; Humans; Isoenzymes; Male; Middle Aged; Myocardial Infarction; Myocardium; Natriuretic Peptide, Brain; Sex Factors; Syndrome; Thrombolytic Therapy; Tirofiban; Treatment Outcome; Troponin; Tyrosine

Topics: Acute Disease; Angina Pectoris; Coronary Artery Bypass; Fibrinolytic Agents; Follow-Up Studies; Heparin; Humans; Myocardial Infarction; Myocardial Ischemia; Platelet Glycoprotein GPIIb-IIIa Complex; Syndrome; Tirofiban; Treatment Outcome; Tyrosine

Topics: Acute Disease; Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Biomarkers; Coronary Stenosis; Creatine Kinase; Creatine Kinase, MB Form; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heparin; Humans; Intraoperative Complications; Isoenzymes; Male; Middle Aged; Myocardial Ischemia; Platelet Aggregation Inhibitors; Prevalence; Risk Factors; Syndrome; Tirofiban; Treatment Outcome; Troponin I; Tyrosine

Topics: Acute Disease; Angina Pectoris; Female; Fibrinolytic Agents; Heparin; Humans; Male; Myocardial Infarction; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Treatment Outcome; Tyrosine

Topics: Acute Disease; Anticoagulants; Aspirin; Biomarkers; C-Reactive Protein; Drug Therapy, Combination; Follow-Up Studies; Heparin; Humans; Incidence; Myocardial Infarction; Myocardial Ischemia; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Peptide Fragments; Predictive Value of Tests; Risk; Risk Assessment; Syndrome; Tirofiban; Troponin T; Tyrosine

Topics: Acute Disease; Aged; Coronary Disease; Dalteparin; Drug Therapy, Combination; Female; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Treatment Outcome; Tyrosine

Topics: Acute Disease; Clopidogrel; Coronary Disease; Diabetes Mellitus; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Saphenous Vein; Stents; Ticlopidine; Tirofiban; Tyrosine

Topics: Abciximab; Acute Disease; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Coronary Angiography; Eptifibatide; Female; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Tirofiban; Treatment Outcome; Tyrosine

Topics: Abciximab; Acute Disease; Aged; Angina, Unstable; Antibodies, Monoclonal; Clopidogrel; Creatine Kinase, MB Form; Electrocardiography; Female; Humans; Immunoglobulin Fab Fragments; Male; Myocardial Infarction; Necrosis; Prospective Studies; Syndrome; Ticlopidine; Time Factors; Tirofiban; Troponin I; Tyrosine

Topics: Acute Disease; Aged; Biomarkers; Coronary Disease; Endothelium; Female; Humans; Male; Middle Aged; Neutrophils; Oxidative Stress; Time Factors; Tirofiban; Tyrosine

Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Disease; Drug Monitoring; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Platelet Function Tests; Prospective Studies; Syndrome; Tirofiban; Tyrosine

Topics: Acute Disease; Aged; C-Reactive Protein; Coronary Disease; Female; Follow-Up Studies; Humans; Lipoproteins, LDL; Male; Middle Aged; Prognosis; Risk Factors; Simvastatin; Survival Analysis; Tirofiban; Tyrosine

Topics: Abciximab; Acute Disease; Antibodies, Monoclonal; Anticoagulants; Coronary Disease; Drug Therapy, Combination; Enoxaparin; Eptifibatide; Feasibility Studies; Humans; Immunoglobulin Fab Fragments; Injections, Intravenous; North America; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Safety; Tirofiban; Tyrosine

Topics: Acute Disease; Aged; Angina, Unstable; Anticoagulants; Canada; Cardiac Catheterization; Double-Blind Method; Female; Heparin; Hospitals; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Proportional Hazards Models; Prospective Studies; Survival Analysis; Syndrome; Tirofiban; Treatment Outcome; Tyrosine

Topics: Acetates; Acute Disease; Aged; Coronary Disease; Double-Blind Method; Electrocardiography; Endpoint Determination; Female; Hemorrhage; Humans; Infusions, Intravenous; Male; Middle Aged; Odds Ratio; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Secondary Prevention; Survival Rate; Treatment Outcome; Troponin T; Tyrosine

Topics: Acute Disease; Aged; Biomarkers; Coronary Disease; Drug Therapy, Combination; Female; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Risk Factors; Survival Rate; Tirofiban; Troponin I; Tyrosine

Topics: Acute Disease; Aged; Aged, 80 and over; Animals; Biomarkers; Carbon Radioisotopes; Chromatography, High Pressure Liquid; Female; Humans; Inflammation; Injections, Intravenous; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Middle Aged; NADPH Oxidases; Neutrophils; Oxidative Stress; Proteins; Sepsis; Spectrometry, Mass, Electrospray Ionization; Tyrosine; Urine

Topics: Acute Disease; Aged; Angina, Unstable; Anticoagulants; Biomarkers; Coronary Disease; Creatine Kinase; Creatine Kinase, MB Form; Electrocardiography; Endpoint Determination; Follow-Up Studies; Heparin; Humans; Isoenzymes; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Predictive Value of Tests; Risk Assessment; Survival Analysis; Syndrome; Tirofiban; Treatment Outcome; Tyrosine

Topics: Acetates; Acute Disease; Aged; Coronary Disease; Double-Blind Method; Endpoint Determination; Female; Hemorrhage; Humans; Incidence; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Syndrome; Titrimetry; Treatment Outcome; Tyrosine

Topics: Abciximab; Acute Disease; Aged; Antibodies, Monoclonal; Blood Vessel Prosthesis Implantation; Coronary Artery Disease; Disease-Free Survival; Double-Blind Method; Female; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Odds Ratio; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Complications; Postoperative Hemorrhage; Prospective Studies; Severity of Illness Index; Stents; Thrombocytopenia; Tirofiban; Treatment Outcome; Tyrosine

Topics: Acute Disease; Aged; Coronary Artery Disease; Creatinine; Double-Blind Method; Female; Fibrinolytic Agents; Hemorrhage; Heparin; Humans; Injections, Intravenous; Male; Middle Aged; Odds Ratio; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Renal Insufficiency; Risk Assessment; Risk Factors; Tirofiban; Treatment Outcome; Tyrosine

Topics: Acute Disease; Adult; Amino Acids; Bilirubin; Clinical Trials as Topic; Electrolytes; Female; Glucose; Hepatic Encephalopathy; Humans; Male; Phenylalanine; Prothrombin Time; Renal Dialysis; Tyrosine

Topics: Acetylcarnitine; Acute Disease; Anesthesia; Cardiopulmonary Bypass; Double-Blind Method; Extracorporeal Circulation; Fumarates; Glycolysis; Hemodynamics; Humans; Hypoxia, Brain; Lactates; Pyruvates; Succinates; Tyrosine

Topics: Acute Disease; Animals; c-Mer Tyrosine Kinase; Ceruletide; Chemokine CXCL2; China; Mice; Mice, Inbred C57BL; Neutrophil Infiltration; Pancreatitis, Acute Necrotizing; Trypsinogen; Tyrosine

Topics: Acute Disease; Animals; Biodiversity; Chromatography, High Pressure Liquid; Computational Biology; Dietary Supplements; Disease Management; Disease Models, Animal; Disease Susceptibility; Gastrointestinal Microbiome; Graft vs Host Disease; Intestinal Mucosa; Mass Spectrometry; Metabolome; Metabolomics; Metagenomics; Mice; Phenotype; RNA, Ribosomal, 16S; Tyrosine

Topics: Acute Disease; Amino Acids, Branched-Chain; Animals; Behavior, Animal; Bipolar Disorder; Caseins; Cerebral Cortex; Corpus Striatum; Disease Models, Animal; Dopamine; Male; Peptide Fragments; Rats; Rats, Sprague-Dawley; Serotonin; Tryptophan; Tyrosine

Topics: Acute Disease; Adult; Aged; Amino Acids; Anxiety Disorders; C-Reactive Protein; Chronic Disease; Depression; Depressive Disorder; Female; Humans; Inflammation; Kynurenine; Male; Mental Disorders; Mental Health; Middle Aged; Neurotransmitter Agents; Phenylalanine; Prospective Studies; Tryptophan; Tyrosine

Topics: 3-Hydroxybutyric Acid; Acute Disease; Aged; Aged, 80 and over; Biomarkers; Citric Acid; Comorbidity; Female; Heart Failure; Humans; Male; Metabolome; Metabolomics; Middle Aged; Prognosis; ROC Curve; Time Factors; Tyrosine

Topics: Acute Disease; Acute Kidney Injury; Amylases; Animals; Cytokines; Hydrogen; Kidney; Male; Neutrophil Infiltration; NF-kappa B; Oxidative Stress; Pancreatitis; Rats; Rats, Wistar; Reactive Oxygen Species; Signal Transduction; Sodium Chloride; Taurocholic Acid; Tyrosine

Topics: Acute Disease; Adult; Aged; Aneurysm, Ruptured; Anticoagulants; Aspirin; Cerebral Hemorrhage; Clopidogrel; Endovascular Procedures; Female; Heparin, Low-Molecular-Weight; Humans; Hydrocephalus; Intracranial Aneurysm; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Thromboembolism; Ticlopidine; Tirofiban; Tyrosine; Ventriculostomy

Topics: Acute Disease; Animals; Benzamides; Chronic Disease; Colitis; Colon; Cytokines; Dextran Sulfate; Disease Models, Animal; Epithelial Cells; Female; Fibroblasts; Galectin 3; Humans; Inflammation; Interleukin-10; Interleukin-4; Interleukin-6; Interleukin-8; Intestinal Mucosa; Mice; Mice, Inbred BALB C; Tyrosine

Topics: Acute Disease; Aged; Carotid Artery Diseases; Carotid Artery, Internal; Female; Fluorescein Angiography; Humans; Intracranial Aneurysm; Magnetic Resonance Imaging; Male; Platelet Aggregation Inhibitors; Retinal Artery Occlusion; Stents; Tirofiban; Tomography, Optical Coherence; Tyrosine; Visual Acuity

Topics: Acute Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Enzyme Activation; Glycyrrhizic Acid; Intercellular Adhesion Molecule-1; Interleukin-1beta; Lipid Peroxidation; Lung; Male; Mice; Neutrophils; NF-kappa B; P-Selectin; Peroxynitrous Acid; Pleurisy; Poly Adenosine Diphosphate Ribose; STAT3 Transcription Factor; Tumor Necrosis Factor-alpha; Tyrosine

Topics: Acute Disease; Animals; Antioxidants; Apoptosis; Calbindin 2; Disease Models, Animal; In Situ Nick-End Labeling; Lutein; Male; Mice; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; Oxidative Stress; Poly Adenosine Diphosphate Ribose; Reperfusion Injury; Retinal Diseases; Retinal Ganglion Cells; S100 Calcium Binding Protein G; Tyrosine

Topics: Acute Disease; Humans; Male; Middle Aged; Thrombocytopenia; Tirofiban; Tyrosine

Topics: Acute Disease; Animals; Blotting, Western; Electrophoresis, Polyacrylamide Gel; Glutamic Acid; Hippocampus; Male; Mass Spectrometry; Mitochondria; Nerve Tissue Proteins; Nitrates; Oxygen Consumption; Proteomics; Rats; Rats, Sprague-Dawley; Smoke Inhalation Injury; Subcellular Fractions; Succinates; Tyrosine

Topics: Acute Coronary Syndrome; Acute Disease; Angina, Unstable; Coronary Angiography; Coronary Artery Bypass, Off-Pump; Follow-Up Studies; Heparin; Humans; Infusions, Intravenous; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Count; Platelet Transfusion; Postoperative Complications; Preoperative Care; Risk Assessment; Severity of Illness Index; Thrombocytopenia; Thrombosis; Tirofiban; Treatment Outcome; Tyrosine

Topics: Acute Disease; Animals; Annexin A5; Blotting, Western; Caspases; Cell Death; Cell Line; Cytoprotection; Drug Delivery Systems; Enzyme Activation; Fluoresceins; Free Radical Scavengers; Glycolates; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Lactic Acid; Neurons; Nitric Oxide; Peroxynitrous Acid; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Signal Transduction; Spinal Cord Injuries; Stem Cells; Tyrosine

Topics: Acute Disease; Anemia; Angioplasty, Balloon, Coronary; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Male; Middle Aged; Platelet Aggregation Inhibitors; Severity of Illness Index; Thrombocytopenia; Time Factors; Tirofiban; Treatment Outcome; Tyrosine

Topics: Acute Coronary Syndrome; Acute Disease; Cardiopulmonary Bypass; Coronary Artery Bypass, Off-Pump; Humans; Metabolic Clearance Rate; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Premedication; Risk Factors; Thrombocytopenia; Tirofiban; Tyrosine

Topics: Acute Disease; Adult; Altitude Sickness; Biomarkers; Blood-Brain Barrier; Brain; Free Radicals; Headache; Health Surveys; Humans; Hypoxia; Male; Nerve Growth Factors; Oxidative Stress; Oxygen; Phosphopyruvate Hydratase; Regional Blood Flow; Retrospective Studies; Risk Factors; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Tyrosine

Topics: Acute Disease; Animals; Apoptosis; bcl-2-Associated X Protein; Cell Adhesion Molecules; Cytokines; Fas Ligand Protein; Flavonoids; I-kappa B Proteins; Inflammation Mediators; Male; Mice; Mitogen-Activated Protein Kinases; Multiple Organ Failure; Neutrophil Infiltration; NF-KappaB Inhibitor alpha; Nitric Oxide; Nitric Oxide Synthase Type II; p38 Mitogen-Activated Protein Kinases; Peritonitis; Phosphorylation; Poly(ADP-ribose) Polymerases; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Systemic Inflammatory Response Syndrome; Time Factors; Transcription Factor RelA; Tyrosine; Zymosan

Topics: Acute Disease; Animals; Chemokine CX3CL1; Colitis; CX3C Chemokine Receptor 1; Cytokines; Dextran Sulfate; Macrophages; Mice; Mice, Inbred BALB C; Nitric Oxide Synthase Type II; Receptors, Chemokine; Tyrosine

Topics: Acute Disease; Aldehyde Reductase; Animals; Calcium Signaling; Glucose; Glutathione; Heart; Hyperglycemia; In Vitro Techniques; Lactic Acid; Male; Myocardial Contraction; Myocardium; Oxidation-Reduction; Oxidative Stress; Perfusion; Peroxynitrous Acid; Pyruvic Acid; Rats; Rats, Sprague-Dawley; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Signal Transduction; Superoxides; Tyrosine

Topics: Acute Disease; Alanine Transaminase; Aldehydes; Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; bcl-2-Associated X Protein; Caspase 8; Female; Gene Expression Regulation; Hemorrhage; Inflammation; Interleukin-6; L-Lactate Dehydrogenase; Liver; NF-kappa B; Oxidative Stress; Plant Extracts; Polyphenols; Rats; Rats, Inbred Lew; Resuscitation; RNA; Tea; Tyrosine

Topics: Acute Disease; Adenosine; Adenosine A2 Receptor Agonists; Animals; bcl-2-Associated X Protein; Carrageenan; Cytokines; Enzyme Activation; Fas Ligand Protein; Gene Expression Regulation, Enzymologic; I-kappa B Proteins; Intercellular Adhesion Molecule-1; Lipid Peroxidation; Male; Mice; NF-KappaB Inhibitor alpha; Nitrates; Nitric Oxide Synthase Type II; Nitrites; P-Selectin; Peroxidase; Phenethylamines; Pleurisy; Pneumonia; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Receptor, Adenosine A2A; Transcription Factor RelA; Tyrosine

Topics: Acute Disease; Aldehydes; Analgesics, Opioid; Animals; Antioxidants; Blood-Brain Barrier; Capillary Permeability; Carbon Radioisotopes; Codeine; Cyclic N-Oxides; Cysteine Proteinase Inhibitors; Hyperalgesia; Male; Membrane Proteins; Neuralgia; Neuritis; Occludin; Oxidative Stress; Rats; Rats, Sprague-Dawley; Spin Labels; Sucrose; Tight Junctions; Tyrosine; Xenobiotics

Topics: Acute Disease; Adult; Blood Flow Velocity; Brain Ischemia; Cerebral Angiography; Diffusion Magnetic Resonance Imaging; Female; Fibrinolytic Agents; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Retrospective Studies; Stroke; Tirofiban; Treatment Outcome; Tyrosine

Topics: Acute Disease; Alcohol Drinking; Alcoholism; Animals; Argininosuccinate Synthase; Chronic Disease; Cytochrome P-450 CYP2E1; Disease Models, Animal; Down-Regulation; Ethanol; Female; Hepatocytes; Immunohistochemistry; Lipid Peroxidation; Liver Diseases, Alcoholic; Male; Mice; Nitric Oxide; Oxidative Stress; Random Allocation; Rats; Tyrosine

Topics: Acute Disease; Adult; Coronary Angiography; Electrocardiography; Heart Valve Prosthesis; Humans; Male; Mitral Valve Insufficiency; Myocardial Infarction; Platelet Aggregation Inhibitors; Postpartum Period; Thrombosis; Tirofiban; Tyrosine

Topics: Acute Disease; Animals; Arginine; Body Weight; Cell Proliferation; Cytokines; Dose-Response Relationship, Drug; Humans; Immunomodulation; Infusions, Parenteral; Leukocyte Count; Leukocytes; Male; Nitrates; Nitric Oxide Synthase; Nitrites; Organ Size; Parenteral Nutrition; Peritonitis; Rats; Rats, Wistar; Spleen; Tyrosine

Topics: Acute Disease; Adenosine Triphosphate; Animals; Arginine; Blood Pressure; Enzyme Inhibitors; Female; Glutathione; Lipase; Microcirculation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; Oxidation-Reduction; Oximetry; Oxygen Consumption; Pancreas Transplantation; Pancreatitis; Regional Blood Flow; Reperfusion Injury; Swine; Tyrosine; Vascular Resistance

Topics: Acute Disease; Animals; Asbestos; Asbestosis; Bronchoalveolar Lavage Fluid; Chemotaxis; Enzyme Induction; Gene Expression Regulation; Inflammation; L-Lactate Dehydrogenase; Lung; Mice; Mice, Inbred C57BL; Mice, Knockout; Neutrophils; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Oxidation-Reduction; Peroxidase; RNA, Messenger; Tumor Necrosis Factor-alpha; Tyrosine

Topics: Acute Disease; Aged; Autoantibodies; Calcium; Case-Control Studies; Cross Reactions; Epitopes; Eptifibatide; Female; Humans; Ligands; Male; Middle Aged; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombocytopenia; Tirofiban; Tyrosine

Topics: Acute Disease; Alcoholic Intoxication; Animals; Carrier Proteins; Central Nervous System Depressants; Ethanol; Eukaryotic Initiation Factor-4F; Glucocorticoids; Hypoglycemic Agents; Insulin; Insulin Receptor Substrate Proteins; Insulin-Like Growth Factor I; Intracellular Signaling Peptides and Proteins; Male; Mitogen-Activated Protein Kinases; Muscle, Skeletal; Phosphoproteins; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Receptor, IGF Type 1; Receptor, Insulin; Ribosomal Protein S6 Kinases; Signal Transduction; Specific Pathogen-Free Organisms; Tyrosine

Topics: Acute Disease; Antimony Sodium Gluconate; Antineoplastic Agents; Antiprotozoal Agents; Cell Cycle; Cell Differentiation; Cell Division; Gene Expression Regulation, Leukemic; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Intracellular Signaling Peptides and Proteins; Leukemia, Myeloid; Nitroblue Tetrazolium; Oxidation-Reduction; Phosphorylation; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Protein Tyrosine Phosphatases; Tretinoin; Tumor Cells, Cultured; Tyrosine

Topics: Acute Disease; Animals; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Furans; Graft Rejection; Graft Survival; Heart Transplantation; Immunohistochemistry; Isoenzymes; Male; Myocardium; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Inbred Lew; Rats, Inbred WF; RNA, Messenger; Transplantation, Homologous; Tyrosine

Topics: Acute Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Combinatorial Chemistry Techniques; Humans; Inflammation; Lipopolysaccharides; Mice; Mice, Inbred BALB C; Receptors, Corticotropin; Receptors, Melanocortin; Structure-Activity Relationship; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Tyrosine

Topics: Acute Disease; Administration, Oral; Adoptive Transfer; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Differentiation; Cell Line; Cell Movement; Chronic Disease; Disease Progression; Encephalomyelitis, Autoimmune, Experimental; Enzyme Inhibitors; Female; Growth Inhibitors; Immunosuppressive Agents; Injections, Intraperitoneal; Lymphocyte Activation; Mice; Mice, Inbred Strains; Microglia; Myelin Basic Protein; NF-kappa B; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Phenylacetates; Phenylbutyrates; Severity of Illness Index; Spinal Cord; T-Lymphocyte Subsets; Transcription Factor RelA; Tyrosine

Topics: Acute Disease; Animals; Autoimmune Diseases; Blood Pressure; Calcium Channel Blockers; Calcium Channels, L-Type; Cytokines; Dihydropyridines; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Heart Rate; Myocarditis; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Peroxynitrous Acid; Rats; Rats, Inbred Lew; Tyrosine

Topics: Acute Disease; Aged; Case-Control Studies; Drug Therapy, Combination; Feasibility Studies; Fibrinolytic Agents; Humans; Pilot Projects; Platelet Glycoprotein GPIIb-IIIa Complex; Recombinant Proteins; Retrospective Studies; Severity of Illness Index; Stroke; Thrombolytic Therapy; Time Factors; Tirofiban; Tissue Plasminogen Activator; Treatment Outcome; Tyrosine

Topics: Acute Disease; Anemia, Sickle Cell; Animals; Disease Models, Animal; Hemoglobin, Sickle; HSP90 Heat-Shock Proteins; Humans; Hypoxia; Lung Diseases; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Tyrosine

Topics: Acute Disease; Animals; Anthocyanins; Carrageenan; Dinoprostone; Exudates and Transudates; Fruit; Glucosides; Immunohistochemistry; Inflammation; Intercellular Adhesion Molecule-1; Lipid Peroxidation; Lung; Male; Malondialdehyde; Neutrophils; Nitrates; Nitrites; Peroxidase; Plant Extracts; Pleurisy; Poly(ADP-ribose) Polymerases; Rats; Rats, Sprague-Dawley; Time Factors; Tyrosine

Topics: Acute Disease; Aged; Anticoagulants; Coronary Disease; Enoxaparin; Hematoma; Humans; Male; Partial Thromboplastin Time; Platelet Aggregation Inhibitors; Retroperitoneal Space; Tirofiban; Tyrosine

Topics: Acute Disease; Aged; Aged, 80 and over; Biomarkers; Coronary Disease; Drug Utilization Review; Electrocardiography; Eptifibatide; Female; Formularies, Hospital as Topic; Humans; Inpatients; Male; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Practice Guidelines as Topic; Retrospective Studies; Tirofiban; Tyrosine

Topics: Acute Disease; Analysis of Variance; Animals; Blotting, Western; Calpain; Ceruletide; Disease Models, Animal; Immunohistochemistry; Intercellular Adhesion Molecule-1; Lipid Peroxidation; Male; Mice; NF-kappa B; Nitric Oxide Synthase; Pancreatitis; Poly(ADP-ribose) Polymerases; Random Allocation; Respiratory Distress Syndrome; Tyrosine

Topics: Abdomen; Acute Disease; Animals; Hemorrhage; Insulin Receptor Substrate Proteins; Insulin Resistance; JNK Mitogen-Activated Protein Kinases; Liver; Male; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Phosphoproteins; Phosphorylation; Rats; Serine; Tumor Necrosis Factor-alpha; Tyrosine; Wounds and Injuries

Topics: Acute Disease; Angina, Unstable; Collateral Circulation; Coronary Artery Bypass; Diabetes Mellitus, Type 2; Female; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Middle Aged; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; RNA, Messenger; Superoxides; Transcription Factors; Tyrosine; Vascular Endothelial Growth Factor A; Ventricular Function

Topics: Abciximab; Acute Disease; Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Aspirin; Biomarkers; Clopidogrel; Combined Modality Therapy; Coronary Angiography; Coronary Circulation; Electrocardiography; Female; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Ischemia; Myocardial Reperfusion Injury; Platelet Aggregation Inhibitors; Prospective Studies; Risk; Ticlopidine; Tirofiban; Troponin I; Tyrosine; Ultrasonography

Topics: Acute Disease; Adrenergic beta-Antagonists; Amidines; Animals; Benzylamines; Blood Pressure; Depression, Chemical; Diabetes Mellitus, Experimental; Male; Myocardial Contraction; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Norepinephrine; Propranolol; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; Tyrosine; Vascular Resistance

Topics: Acetylation; Acute Disease; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Bone Marrow Cells; Cell Cycle; Drug Resistance, Neoplasm; Drug Synergism; Enzyme Inhibitors; Female; Fusion Proteins, bcr-abl; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Imatinib Mesylate; In Vitro Techniques; Leukemia, Myeloid; Mice; Mice, Inbred BALB C; Phosphorylation; Piperazines; Pyrimidines; Tumor Cells, Cultured; Tyrosine

Topics: Acute Disease; Animals; Brain; Brain Injuries; Brain Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Male; Necrosis; Neoplasm Recurrence, Local; Quaternary Ammonium Compounds; Radiation Injuries, Experimental; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Tyrosine

Topics: Abciximab; Acute Disease; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Brain Ischemia; Chemotherapy, Adjuvant; Eptifibatide; Female; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Peptides; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Stroke; Thrombolytic Therapy; Tirofiban; Tyrosine

Topics: Acute Disease; Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Circulation; Coronary Thrombosis; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fibrinolytic Agents; Follow-Up Studies; Humans; Male; Myocardial Infarction; Risk Assessment; Stents; Tirofiban; Tyrosine; Vascular Patency

Topics: Acute Disease; Animals; Animals, Genetically Modified; Antioxidants; Blood Pressure; Cyclic N-Oxides; Dinoprost; Enzyme Inhibitors; Glomerular Filtration Rate; Hypertension, Renal; Kidney; Male; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Renal Circulation; Renin; Sodium; Spin Labels; Tyrosine

Topics: Acute Disease; Angioplasty, Balloon, Coronary; Animals; Coronary Thrombosis; Dogs; Integrin alphaVbeta3; Male; Models, Animal; Myocardial Infarction; Piperidines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrimidines; Random Allocation; Tirofiban; Tyrosine

Topics: Abciximab; Acute Disease; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Chemotherapy, Adjuvant; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Tyrosine

Topics: Acute Disease; Aged; Angioplasty, Balloon; Anticoagulants; Feasibility Studies; Female; Follow-Up Studies; Hirudins; Humans; Ischemia; Leg; Male; Myocardial Ischemia; Peptide Fragments; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Recombinant Proteins; Retrospective Studies; Thrombin; Tirofiban; Treatment Outcome; Tyrosine

Topics: Acute Disease; Animals; Disease Models, Animal; Enzyme Inhibitors; Gene Expression; Graft Rejection; Heart Transplantation; Lysine; Nitric Oxide Synthase Type II; Oxidative Stress; Peroxynitrous Acid; Protein Processing, Post-Translational; Rats; Rats, Inbred Lew; Rats, Inbred WF; Superoxide Dismutase; Tyrosine

Topics: Acute Disease; Animals; Bone Marrow Transplantation; Cell Differentiation; Cell Fusion; Chronic Disease; Disease Models, Animal; Homogentisate 1,2-Dioxygenase; Homogentisic Acid; Hydrolases; Kidney Diseases; Kidney Tubules, Proximal; Male; Mice; Mice, Knockout; Necrosis; Regeneration; Tyrosine; Urothelium

Topics: Acute Disease; Aged; Aged, 80 and over; Autoantibodies; Coronary Disease; Female; Humans; Male; Middle Aged; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Purpura, Thrombocytopenic, Idiopathic; Tirofiban; Tyrosine

Topics: Acute Disease; Amylases; Animals; Enzyme Inhibitors; Lipase; Lipid Peroxidation; Male; Mice; Mice, Inbred Strains; Neutrophils; Nitric Oxide; Pancreas; Pancreatitis; Peroxynitrous Acid; Poly(ADP-ribose) Polymerases; Protein-Tyrosine Kinases; Signal Transduction; Tumor Necrosis Factor-alpha; Tyrosine; Tyrphostins

Topics: Acute Disease; Animals; Biomarkers; Chagas Cardiomyopathy; Enzyme-Linked Immunosorbent Assay; Immunohistochemistry; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Nitric Oxide; Parasitemia; Tyrosine

Topics: Acute Disease; alpha-Tocopherol; Animals; Antioxidants; Burns; Disease Models, Animal; Extravascular Lung Water; gamma-Tocopherol; Lipids; Lung; Lung Injury; Pulmonary Gas Exchange; Pulmonary Wedge Pressure; Sheep; Smoke Inhalation Injury; Tyrosine

Topics: Acute Disease; Diagnosis, Differential; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombocytopenia; Tirofiban; Tyrosine

Topics: Acute Disease; Carbazoles; Cell Division; Cell Line, Tumor; Cell Survival; Cytokines; Enzyme Inhibitors; fms-Like Tyrosine Kinase 3; Humans; Indoles; Interleukin-2; Janus Kinase 2; Janus Kinase 3; Leukemia, Myeloid; Neoplasm Proteins; Oncogene Proteins, Fusion; Phosphorylation; Protein Kinase C; Signal Transduction; Stem Cells; Tyrosine

Topics: Acute Disease; Adult; Angina, Unstable; Blood Transfusion; Cerebral Hemorrhage; Creatinine; Disease Susceptibility; Dose-Response Relationship, Drug; Eptifibatide; Glomerular Filtration Rate; Hemorrhage; Hemorrhagic Disorders; Humans; Kidney Diseases; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Practice Guidelines as Topic; Registries; Sex Characteristics; Tirofiban; Tyrosine

Topics: Acute Disease; Angina, Unstable; Angioplasty, Balloon, Coronary; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Platelet Aggregation Inhibitors; Syndrome; Time Factors; Tirofiban; Tyrosine

Topics: Acute Disease; Angioplasty, Balloon, Coronary; Blood Vessel Prosthesis Implantation; Coronary Stenosis; Humans; Infusions, Intravenous; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Count; Stents; Thrombocytopenia; Tirofiban; Tyrosine

Topics: Acute Disease; Administration, Oral; Aged; Anticoagulants; Brain Ischemia; Contraindications; Drug Therapy, Combination; Female; Fibrinolytic Agents; Humans; Injections, Intra-Arterial; Injections, Intravenous; Male; Middle Aged; Patient Selection; Stroke; Thrombolytic Therapy; Tirofiban; Tyrosine

Topics: Acute Disease; Arginine; Bacterial Infections; Biomarkers; Blood Pressure; C-Reactive Protein; Calcitonin; Calcitonin Gene-Related Peptide; Chromatography, High Pressure Liquid; Creatinine; Disease Progression; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Glycoproteins; Humans; Inflammation; Interleukin-6; Male; Middle Aged; Nitric Oxide Synthase; Protein Precursors; Severity of Illness Index; Tyrosine

Topics: Acute Disease; Animals; Arthritis, Experimental; Hindlimb; Hyperalgesia; Injections, Intra-Articular; Knee Joint; Male; Neutrophils; Nitric Oxide; Peroxidase; Peroxynitrous Acid; Rats; Rats, Wistar; Reactive Nitrogen Species; Synovial Fluid; Tyrosine; Uric Acid; Zymosan

Topics: Acute Disease; Animals; Doxorubicin; Heart Diseases; Iridoid Glucosides; Iridoids; Male; Malondialdehyde; Nitrates; Nitric Oxide Synthase Type II; Nitrosation; Oleaceae; Oxidative Stress; Pyrans; Rats; Rats, Wistar; Tyrosine

Topics: Acute Disease; Animals; Bilirubin; Biomarkers; Blotting, Western; Dipyrone; Disease Models, Animal; Disease Progression; Free Radical Scavengers; Graft Rejection; Heart Transplantation; Heme Oxygenase-1; Immunohistochemistry; Myocardium; Nitric Oxide; Oxidation-Reduction; Prognosis; Rats; Transplantation, Homologous; Tyrosine

Topics: Acute Disease; Aldehydes; Animals; Biomarkers; Brain Injuries; Cyclosporine; Dose-Response Relationship, Drug; Immunoblotting; Lipid Peroxidation; Male; Mice; Mitochondrial Diseases; Oxidative Stress; Oxygen Consumption; Structure-Activity Relationship; Tyrosine

Topics: Acute Disease; Animals; Asthma; beta-N-Acetylhexosaminidases; Biomarkers; Bronchoalveolar Lavage Fluid; Calgranulin B; Electrophoresis, Gel, Two-Dimensional; Humans; Hypersensitivity, Immediate; Lectins; Lung; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinases; Mice; Mice, Knockout; Protein Processing, Post-Translational; Proteomics; Subtraction Technique; Th2 Cells; Tyrosine

Topics: Acute Disease; Aged; Biomarkers; Female; Humans; Leukocyte Count; Male; Middle Aged; Myocardial Infarction; Peroxidase; Sensitivity and Specificity; Taiwan; Tyrosine

Topics: Acute Disease; Aged; Female; Humans; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombocytopenia; Tirofiban; Tyrosine

Topics: Acute Disease; Animals; Biomarkers; Carrageenan; Edema; Etanercept; Fas Ligand Protein; Gene Deletion; Hindlimb; Immunoglobulin G; Immunohistochemistry; Intercellular Adhesion Molecule-1; Interleukin-1; Lung; Male; Mice; Mice, Knockout; Models, Animal; P-Selectin; Pleurisy; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Thiobarbituric Acid Reactive Substances; Tumor Necrosis Factor-alpha; Tyrosine

Topics: Acute Disease; Adolescent; Adult; Biopsy; Child; Child, Preschool; Complement C1s; Humans; Hydrolysis; Hypertrophy; Middle Aged; Palatine Tonsil; Recurrence; Tonsillitis; Tyrosine

Topics: Acute Disease; Alanine; Animals; Body Weight; Glucose; Insulin; Lactates; Male; Muscle Proteins; Rats; Rats, Inbred Strains; Time Factors; Tyrosine; Uremia

Topics: 3,4-Dihydroxyphenylacetic Acid; Acute Disease; Amino Acids; Ammonia; Animals; Biogenic Monoamines; Body Weight; Cerebral Cortex; Chronic Disease; Dialysis; Disease Models, Animal; Dopamine; Extracellular Space; Hepatic Encephalopathy; Hydroxyindoleacetic Acid; Male; Norepinephrine; Phenylalanine; Rats; Rats, Wistar; Serotonin; Tryptophan; Tyrosine

Topics: Acute Disease; Amino Acid Metabolism, Inborn Errors; Bacteremia; Clinical Enzyme Tests; Cytomegalovirus Infections; Female; Humans; Hydrolases; Infant; Meningitis, Pneumococcal; Pneumococcal Infections; Tyrosine

Topics: Acute Disease; Animals; Biological Transport; Chronic Disease; Intestinal Mucosa; Liver; Liver Circulation; Male; Phenylalanine; Portal Vein; Proteins; Rats; Rats, Inbred Lew; Starvation; Tyrosine; Viscera

Topics: Acute Disease; Cell Division; DNA Fingerprinting; Erythropoietin; Humans; Karyotyping; Leukemia, Myeloid; Male; Middle Aged; Neoplasm Proteins; Phosphorylation; Receptors, Erythropoietin; Tumor Cells, Cultured; Tumor Stem Cell Assay; Tyrosine

Topics: Acute Disease; Animals; Chronic Disease; Encephalomyelitis, Autoimmune, Experimental; Female; Immunohistochemistry; Mice; Mice, Inbred Strains; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Recurrence; Remission Induction; Serum Albumin, Bovine; Spinal Cord; Tyrosine

Topics: Acute Disease; Adolescent; Adult; Analysis of Variance; Antibodies, Monoclonal; Blotting, Western; Colitis, Ulcerative; Colon; Enzyme Induction; Female; Humans; Immunohistochemistry; Intestinal Mucosa; Isoenzymes; Male; Middle Aged; Nitrates; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Tyrosine

Topics: Acute Disease; Blotting, Western; Calcium-Calmodulin-Dependent Protein Kinases; DNA-Binding Proteins; DNA, Neoplasm; Enzyme Activation; Humans; Leukemia, Myeloid; Milk Proteins; Mitogen-Activated Protein Kinase 1; Phosphorylation; Protein Binding; STAT3 Transcription Factor; STAT5 Transcription Factor; Trans-Activators; Tumor Cells, Cultured; Tumor Suppressor Proteins; Tyrosine

Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Antibodies; Antibodies, Monoclonal; Astrocytes; Brain; Chronic Disease; Diffuse Cerebral Sclerosis of Schilder; Female; Glial Fibrillary Acidic Protein; Humans; Immunohistochemistry; Macrophages; Male; Middle Aged; Monocytes; Multiple Sclerosis; Myelin Sheath; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Tyrosine

Topics: Acute Disease; Adult; Flow Cytometry; Granulocytes; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid; Lymphocytes; Monocytes; Neoplasm Proteins; Phosphorylation; Phosphotyrosine; Tyrosine

Topics: Acute Disease; Adolescent; Amino Acid Metabolism, Inborn Errors; Child; Child, Preschool; Chronic Disease; Female; Genetic Diseases, Inborn; Genotype; Heterozygote; Homozygote; Humans; Hydrolases; Infant; Infant, Newborn; Liver; Mutation; Pedigree; Tyrosine

Topics: Abciximab; Acute Disease; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Coronary Disease; Eptifibatide; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Peptides; Platelet Aggregation Inhibitors; Premedication; Syndrome; Tirofiban; Tyrosine

Topics: Acute Disease; Administration, Inhalation; Coronary Disease; Humans; Nitric Oxide; Platelet Aggregation Inhibitors; Syndrome; Tirofiban; Tyrosine; United States; United States Food and Drug Administration; Vasodilator Agents

Topics: 4-Hydroxyphenylpyruvate Dioxygenase; Acute Disease; Amino Acid Metabolism, Inborn Errors; Aminolevulinic Acid; Cyclohexanones; Enzyme Inhibitors; Female; Follow-Up Studies; Heptanoates; Humans; Infant; Infant, Newborn; Liver Failure; Male; Methionine; Nitrobenzoates; Porphobilinogen Synthase; Treatment Outcome; Tyrosine

Topics: Acute Disease; Codon; Cysteine; Hemochromatosis; Humans; Leukemia, Myeloid; Mutation; Prevalence; Tyrosine

Topics: Abciximab; Acute Disease; Angina, Unstable; Antibodies, Monoclonal; Anticoagulants; Coronary Disease; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Myocardial Ischemia; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Safety; Tirofiban; Tyrosine

Topics: Acute Disease; Analysis of Variance; Animals; Aquaporin 1; Aquaporins; Capillary Permeability; Disease Models, Animal; Endothelial Growth Factors; Immunoassay; Immunohistochemistry; Isoenzymes; Lymphokines; Male; Nitric Oxide Synthase; Peritoneal Dialysis; Peritoneum; Peritonitis; Protein Isoforms; Rats; Rats, Sprague-Dawley; Reference Values; Sensitivity and Specificity; Tyrosine; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

Topics: Acute Disease; Amino Acids, Branched-Chain; Female; Hepatitis, Viral, Human; Humans; Male; Tyrosine

Topics: Acute Disease; Animals; Chromatography, High Pressure Liquid; Graft Rejection; Heart Transplantation; Male; Myocardium; Rats; Rats, Inbred F344; Rats, Inbred Lew; Time Factors; Transplantation, Homologous; Tyrosine

Topics: Acute Disease; Coronary Disease; Drug Combinations; Fibrinolytic Agents; Heparin; Humans; Myocardial Infarction; Thrombolytic Therapy; Tirofiban; Tyrosine

Topics: Acute Disease; Animals; Bronchoalveolar Lavage Fluid; Enzyme Induction; L-Lactate Dehydrogenase; Lung; Lung Diseases; Male; Nitrates; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Proteins; Radiation Injuries, Experimental; Rats; Rats, Wistar; Tyrosine

Topics: Acute Disease; Adult; alpha 1-Antichymotrypsin; Blood Proteins; Blotting, Western; Carbon Dioxide; Ceruloplasmin; Enzyme Activation; Fibrinogen; Humans; In Vitro Techniques; Nitrates; Nitric Oxide; Oxidative Stress; Precipitin Tests; Respiratory Distress Syndrome; Superoxides; Tyrosine

Topics: Abciximab; Acute Disease; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Combined Modality Therapy; Coronary Disease; Drug Monitoring; Eptifibatide; Female; Humans; Immunoglobulin Fab Fragments; Middle Aged; Nursing Assessment; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Tyrosine

Topics: Abciximab; Acute Disease; Antibodies, Monoclonal; Anticoagulants; Blood Platelets; Coronary Disease; Dose-Response Relationship, Drug; Eptifibatide; Heparin; Humans; Immunoglobulin Fab Fragments; Kinetics; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombin; Thromboplastin; Tirofiban; Tyrosine

Topics: Abciximab; Acute Disease; Adult; Aged; Aged, 80 and over; Angina, Unstable; Antibodies, Monoclonal; Anticoagulants; Aspirin; Clinical Protocols; Coronary Angiography; Coronary Disease; Electrocardiography; Female; Fibrinolytic Agents; Heparin; Hospitalization; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Nitrates; Platelet Aggregation Inhibitors; Prospective Studies; Stents; Tirofiban; Treatment Outcome; Tyrosine

Topics: Acute Disease; Animals; Electron Spin Resonance Spectroscopy; Graft Rejection; Heart Transplantation; In Vitro Techniques; Male; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; omega-N-Methylarginine; Perfusion; Rats; Rats, Inbred ACI; Rats, Inbred Lew; Superoxide Dismutase; Superoxides; Transplantation, Homologous; Tyrosine

Topics: Acute Disease; Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Binding Sites, Antibody; Complement C1q; Complement C3; Female; Free Radicals; Gout; Humans; Hydrogen Peroxide; Hypochlorous Acid; Immunoglobulin G; Male; Neutrophils; Nitrates; Osteoarthritis; Oxidation-Reduction; Oxygen; Rabbits; Receptors, IgG; Serum Albumin, Bovine; Synovial Fluid; Tyrosine

Topics: Abciximab; Acute Disease; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Aspirin; Atherectomy; Clinical Trials as Topic; Combined Modality Therapy; Coronary Disease; Eptifibatide; Fibrinolytic Agents; Heparin; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Syndrome; Tirofiban; Tyrosine; United States; United States Food and Drug Administration

Topics: Acute Disease; Animals; Arthritis; Carrageenan; Chronic Disease; Collagen; Cyclooxygenase 2; Cysteine Proteinase Inhibitors; Glycoproteins; Isoenzymes; Lung; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Pleurisy; Poly Adenosine Diphosphate Ribose; Prostaglandin-Endoperoxide Synthases; Radiography; Rats; Rats, Inbred Lew; Rats, Sprague-Dawley; Tarsus, Animal; Tyrosine

Topics: Abciximab; Acute Disease; Angina, Unstable; Antibodies, Monoclonal; Anticoagulants; Biomarkers; Clinical Trials as Topic; Coronary Disease; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Nadroparin; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prognosis; Retrospective Studies; Risk Factors; Syndrome; Terminology as Topic; Tirofiban; Troponin I; Troponin T; Tyrosine

Topics: Acute Disease; Amidohydrolases; Aminopeptidases; Cell Culture Techniques; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid; Leukemia, Myelomonocytic, Chronic; Macrophage Colony-Stimulating Factor; Neoplasm Proteins; Phosphorylation; Proto-Oncogene Mas; Signal Transduction; Stem Cell Factor; Tyrosine

Topics: Abciximab; Acute Disease; Algorithms; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Combined Modality Therapy; Coronary Disease; Humans; Immunoglobulin Fab Fragments; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Tirofiban; Tyrosine

Topics: Acute Disease; Animals; Antigens, Viral; Blood-Brain Barrier; Borna Disease; Borna disease virus; Brain; Brain Chemistry; Chemotaxis, Leukocyte; Encephalitis, Viral; Female; Free Radical Scavengers; Free Radicals; Gene Expression Profiling; Immunocompetence; Inflammation; Lymphocyte Count; Nerve Tissue Proteins; Neurons; Neuroprotective Agents; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Oxidation-Reduction; Peroxynitrous Acid; Polymerase Chain Reaction; Rats; Rats, Inbred Lew; T-Lymphocyte Subsets; Tyrosine; Uric Acid; Virus Replication

Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Coronary Disease; Eligibility Determination; Female; Health Care Costs; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Random Allocation; Syndrome; Tirofiban; Tyrosine

Topics: Acetates; Acute Disease; Angina, Unstable; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Eptifibatide; Humans; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prognosis; Syndrome; Treatment Outcome; Tyrosine

Topics: Acute Disease; Animals; Bronchoalveolar Lavage Fluid; Chemokine CXCL2; Chemokines; Disease Susceptibility; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Mice, Knockout; Neutrophils; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Ozone; Pneumonia; Proteins; Pulmonary Edema; Tyrosine

Topics: Acrylic Resins; Acrylonitrile; Acute Disease; Amino Acids; Ammonia; Animals; Brain; Cellulose; Copper; Dopamine; Hepatic Encephalopathy; Kidneys, Artificial; Neurotransmitter Agents; Norepinephrine; Octopamine; Renal Dialysis; Swine; Tyrosine

Topics: Acute Disease; Adolescent; Adult; Aged; Chronic Disease; Homogentisic Acid; Humans; Lactates; Leukemia; Lymphoma; Middle Aged; Phenols; Pyruvates; Tyrosine

Topics: Acute Disease; Adjustment Disorders; Adult; Antidepressive Agents; Circadian Rhythm; Female; Humans; Male; Remission, Spontaneous; Sex Factors; Tryptophan; Tyrosine

Topics: Acute Disease; Amino Acid Metabolism, Inborn Errors; Ascorbic Acid; Chronic Disease; Female; Growth Disorders; Hematuria; Humans; Infant, Newborn; Liver; Liver Diseases; Male; Methionine; Pregnancy; Tyrosine

Topics: Acute Disease; Gastroenteritis; Glucagon; Glucagon-Like Peptides; Humans; Infant; Intestinal Absorption; Tyrosine

Topics: Acute Disease; Adolescent; Adult; Amino Acid Metabolism, Inborn Errors; Aminolevulinic Acid; Child; Child, Preschool; Humans; Hypesthesia; Intestinal Pseudo-Obstruction; Muscle Hypertonia; Pain; Peripheral Nerves; Peripheral Nervous System Diseases; Self Mutilation; Tyrosine; Vomiting

Topics: Acute Disease; Adult; Amino Acids; Amino Acids, Branched-Chain; Arteries; Dipeptides; Glutamine; Humans; Intracellular Fluid; Male; Middle Aged; Muscles; Pancreatitis; Parenteral Nutrition, Total; Tyrosine; Veins

Topics: Acute Disease; Animals; Blood Glucose; Corticosterone; Diabetes Mellitus, Experimental; Insulin; Male; Methylhistidines; Muscle Proteins; Muscles; Myofibrils; Peptide Hydrolases; Rats; Rats, Inbred Strains; Time Factors; Tyrosine

Topics: Acute Disease; Animals; Catecholamines; Infections; Male; Peritonitis; Rats; Rats, Inbred Strains; Shock, Hemorrhagic; Tyrosine

Topics: Acute Disease; Adrenalectomy; Animals; Chronic Disease; Dexamethasone; Diabetes Mellitus, Experimental; In Vitro Techniques; Liver; Male; Phenylalanine; Rats; Rats, Inbred Strains; Tyrosine

Topics: Acute Disease; Amino Acid Metabolism, Inborn Errors; Child, Preschool; Humans; Infant; Liver Diseases; Methionine; Phenotype; Tyrosine

Topics: Acute Disease; Amino Acid Metabolism, Inborn Errors; Humans; Infant, Newborn; Liver Diseases; Methionine; Phenotype; Tyrosine

Topics: Acute Disease; Adolescent; Adult; Aged; Aging; Amyloid; Amyloidosis; Arteriosclerosis; Child; Child, Preschool; Chromatography, Gel; Chronic Disease; Diabetes Mellitus; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Iodine Radioisotopes; Middle Aged; Osteoarthritis; Pregnancy; Radioimmunoassay; Tyrosine

Topics: Acetates; Acute Disease; Amino Acids; Animals; Binding Sites; Chemical Phenomena; Chemistry; Chickens; Circular Dichroism; Egg White; Glucosamine; Humans; Hydrogen-Ion Concentration; Leukemia, Myeloid; Mathematics; Mice; Muramidase; Protein Binding; Protein Conformation; Rats; Tryptophan; Tyrosine

Topics: Acute Disease; Amino Acids; Animal Nutritional Physiological Phenomena; Animals; Arginine; Escherichia coli Infections; Gastroenteritis; Leucine; Lysine; Methionine; Nutrition Disorders; Swine; Threonine; Tyrosine

Topics: Acute Disease; Blood Proteins; Body Height; Body Weight; Catecholamines; Child; Child, Preschool; Diet Therapy; Dopamine; Epinephrine; Female; Humans; Infant; Kidney; Kwashiorkor; Male; Norepinephrine; Phenylacetates; Time Factors; Tyrosine; Urine; Vanilmandelic Acid

Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Bipolar Disorder; Chronic Disease; Depression; Diet; Female; Hospitalization; Humans; Length of Stay; Male; Middle Aged; Phenylalanine; Racial Groups; Schizophrenia; Sex Factors; Tryptophan; Tyrosine

Topics: Acute Disease; Adolescent; Adult; Aged; Chronic Disease; Female; Hospitalization; Humans; Length of Stay; Male; Middle Aged; Phenylalanine; Racial Groups; Remission, Spontaneous; Schizophrenia; Sex Factors; Tryptophan; Tyrosine

Topics: Acute Disease; Amylases; Animals; Caseins; Hydrolysis; Male; Nitro Compounds; Pancreas; Pancreatitis; Peptide Hydrolases; Phenylalanine; Rats; Time Factors; Trypsin; Trypsin Inhibitors; Tyrosine

Topics: Acute Disease; Amino Acid Metabolism, Inborn Errors; Chromatography, Paper; Chronic Disease; Humans; Infant; Phenylalanine; Time Factors; Tyrosine

Topics: Acetaminophen; Acute Disease; Adult; Aged; Brain; Dopamine; Fatty Acids, Nonesterified; Female; Halothane; Hepatic Encephalopathy; Hepatitis A; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methionine; Middle Aged; Phenylalanine; Serotonin; Tryptophan; Tyrosine